Loading...
Eversana Life Sciences Services Llc — Busulfan Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #7 buyer for Busulfan · $179.8K import value · 6 shipments · UNITED STATES · DGFT Verified
Eversana Life Sciences Services Llc is the #7 importer of Busulfan from India with $179.8K in import value and 6 verified shipments. Eversana Life Sciences Services Llc holds a 3.6% market share in Busulfan imports based in UNITED STATES. Overall, Eversana Life Sciences Services Llc imports 30 pharmaceutical products worth $95.9M across 11 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $2.0M | 92 | 15 |
| EMCURE PHARMACEUTICALS LIMITED | $1.5M | 109 | 9 |
| FRESENIUS KABI ONCOLOGY LIMITED | $627.6K | 77 | 7 |
| INTAS PHARMACEUTICALS LTD | $324.7K | 16 | 5 |
| SHILPA MEDICARE LIMITED | $150.5K | 5 | 4 |
| SP ACCURE LABS PRIVATE LIMITED | $52.3K | 4 | 2 |
| BRUCK PHARMA PRIVATE LIMITED | $19.1K | 3 | 2 |
| GLS PHARMA LIMITED | $18.4K | 5 | 4 |
| MEDINEX HEALTHCARE | $9.8K | 3 | 1 |
India's top Busulfan suppliers include INTAS PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED. These companies represent the primary source of Busulfan exports from India, serving buyers like Eversana Life Sciences Services Llc in UNITED STATES and other global markets.
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $404.7K | 22 | $18.4K |
| 6 | TILLOMED MALTA LTD | MALTA | $235.8K | 16 | $14.7K |
| 7 | EVERSANA LIFE SCIENCES SERVICES,LLC ★ | UNITED STATES | $179.8K | 6 | $30.0K |
| 9 | ACCORD FARMACEUTICA LTDA | BRAZIL | $150.0K |
What Eversana Life Sciences Services Llc and other importers must comply with to import Busulfan from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $2.7M worth of Busulfan through 369 shipments from 33 suppliers to 44 countries, serving 109 buyers globally. Eversana Life Sciences Services Llc imports $179.8K of this total, accounting for 3.6% of India's Busulfan exports with 6 shipments from UNITED STATES.
Eversana Life Sciences Services Llc's average Busulfan order value is $30.0K per consignment, based on 6 shipments totaling $179.8K. Eversana Life Sciences Services Llc is based in UNITED STATES and ranks #7 among all Busulfan importers from India by value.
Top Indian Busulfan suppliers include INTAS PHARMACEUTICALS LIMITED ($2.0M), EMCURE PHARMACEUTICALS LIMITED ($1.5M), FRESENIUS KABI ONCOLOGY LIMITED ($627.6K), INTAS PHARMACEUTICALS LTD ($324.7K), SHILPA MEDICARE LIMITED ($150.5K). These companies represent the primary source of Busulfan exports from India.
Eversana Life Sciences Services Llc ranks #7 among 109 Busulfan importers from India with a 3.6% market share. The top 3 importers are TILLOMED LABORATORIES LTD ($619.7K), FRESENIUS KABI DEUTSCHLAND GMBH ($426.4K), TILLOMED LABORATORIES LIMITED ($404.7K). Eversana Life Sciences Services Llc processed 6 shipments from UNITED STATES.
Eversana Life Sciences Services Llc also imports these advanced oncology products. Each links to the detailed product page.
Eversana Life Sciences Services Llc imports 30 products worth $95.9M. Beyond Busulfan, top products include Metoprolol, Levothyroxine, Tacrolimus, Tramadol, Clonazepam. View the complete Eversana Life Sciences Services Llc profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Busulfan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Eversana Life Sciences Services Llc's Busulfan imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Eversana Life Sciences Services Llc
Full Company Profile →
30 products · $95.9M total trade · 11 categories
| 3 |
| $50.0K |
| 10 | ACCORD UK | UNITED KINGDOM | $111.6K | 7 | $15.9K |
Eversana Life Sciences Services Llc ranks #7 among 109 Busulfan importers from India. Average shipment value of $30.0K compared to the market average of $24.7K. The closest competitors by value are TILLOMED LABORATORIES LIMITED and TILLOMED MALTA LTD.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 44+ countries, 109+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Eversana Life Sciences Services Llc.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Busulfan. For current order-level data, contact TransData Nexus.